{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:34:02Z","timestamp":1787686442503,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.repc.2021.06.027","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:32:00Z","timestamp":1659047520000},"page":"853-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm"],"prefix":"10.1016","volume":"41","author":[{"given":"Francesc","family":"Formiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chivite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Carmen","family":"Moreno Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Ar\u00e9valo-Lorido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Cerqueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Garc\u00eda Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Trull\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Montero-P\u00e9rez-Barquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2021.06.027_bib0140","first-page":"421","article-title":"Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnostic and therapeutic approach","volume":"16","author":"Duque","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.regg.2019.09.003","article-title":"Heart failure with preserved ejection fraction. A dim light at the end of the tunnel","volume":"54","author":"Formiga","year":"2019","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.repc.2021.06.027_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.regg.2020.01.003","article-title":"Beta-blockers in heart failure with preserved ejection fraction: prescribe or deprescribe?","volume":"55","author":"Formiga","year":"2020","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.repc.2021.06.027_bib0155","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.06.027_bib0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2016.11.239","article-title":"The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies","volume":"228","author":"Fukuta","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/clc.23345","article-title":"Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)","volume":"43","author":"Palau","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers in Heart Failure Collaborative Group. Beta-blockers for heart failure with reduced, midrange, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.06.027_bib0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"J-DHF Investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2021.06.027_bib0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2019.04.067","article-title":"The evolution of \u03b2-blockers in coronary artery disease and heart failure (Part 1\/5)","volume":"74","author":"Joseph","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.recesp.2016.06.027","article-title":"Burden of recurrent hospitalizations following an admission for acute heart failure: preserved versus reduced ejection fraction","volume":"70","author":"Santas","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0190","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","article-title":"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14964 patients in the European Society of Cardiology Heart Failure Long-Term Registry","volume":"39","author":"Zafrir","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.06.027_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.medcli.2017.06.065","article-title":"RICA investigadors. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction","volume":"150","author":"Franco","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.repc.2021.06.027_bib0200","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2021.06.027_bib0205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2021.06.027_bib0210","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2021.06.027_bib0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2021.06.027_bib0220","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.06.027_bib0225","doi-asserted-by":"crossref","first-page":"e1916598","DOI":"10.1001\/jamanetworkopen.2019.16598","article-title":"Association of \u03b2-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.repc.2021.06.027_bib0230","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2014.15241","article-title":"Association between use of \u03b2-blockers and outcomes in patients with heart failure and preserved ejection fraction","volume":"312","author":"Lund","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2021.06.027_bib0235","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","volume":"53","author":"Van Veldhuisen","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2021.06.027_bib0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","article-title":"Hypertensive hypertrophic cardiomyopathy of the elderly","volume":"312","author":"Topol","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2021.06.027_bib0245","first-page":"e006213","article-title":"Heart rate and heart failure with preserved ejection fraction: time to slow \u03b2-blocker use?","volume":"12","author":"Meyer","year":"2019","journal-title":"Circulation: Heart Fail"},{"key":"10.1016\/j.repc.2021.06.027_bib0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2019.01.039","article-title":"Misconceptions and facts about beta-blockers","volume":"132","author":"Argulian","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.repc.2021.06.027_bib0255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2019.08.020","article-title":"Beta-blocker cessation in stable outpatients with heart failure with a preserved ejection fraction","volume":"26","author":"Nambiar","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2021.06.027_bib0260","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.echo.2019.06.017","article-title":"Myocardial strain for identification of \u03b2-blocker responders in heart failure with preserved ejection fraction","volume":"32","author":"Park","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.repc.2021.06.027_bib0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ehf2.12281","article-title":"Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction","volume":"5","author":"Dom\u00ednguez","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.repc.2021.06.027_bib0270","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jchf.2017.12.003","article-title":"Heart rate in heart failure with preserved ejection fraction: another example of the heterogeneity of this syndrome","volume":"6","author":"Palau","year":"2018","journal-title":"JACC Heart Fail"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255122002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255122002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:11:33Z","timestamp":1760109093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255122002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0870255122002761"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2021.06.027","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2021.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}